Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 7, 2007, Pages 1005-1018

  Esrailian, E ^a,b,c   Spiegel, B M R ^a,b,c,d   Targownik, L E ^c,e   Dubinsky, M C ^f   Targan, S R ^f   Gralnek, I M ^c,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF MANITOBA   (Canada)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BALSALAZIDE; CIPROFLOXACIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; OLSALAZINE;

ADULT; ARTICLE; CAPSULE ENDOSCOPY; COLONOSCOPY; COMMUNITY CARE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROHN DISEASE; DEMOGRAPHY; DRUG EFFICACY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PHYSICIAN; PRIORITY JOURNAL; VIGNETTE;

CROHN DISEASE; DATA COLLECTION; DECISION MAKING; GASTROENTEROLOGY; HUMANS; REMISSION INDUCTION;

EID: 34548667905     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03445.x     Document Type: Article

References (33)

1. Centers for Medicare and Medicaid Services. Medicare Pay for Performance (P4P) Initiatives. Available at: http://www.cms.hhs.gov/apps/media/press/ release.asp?Counter=1343, accessed on June 2006
2. Donabedian A. The quality of care. How can it be assessed JAMA 1988 260 : 1743 8.
3. Brook RH, Lohr KN. Efficacy, effectiveness, variations, and quality boundary-crossing research. Med Care 1985 23 : 710 22.
4. Blondel-Kucharski F, Chircop C, Marquis P, et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 2001 90 : 2915 20
5. Feagan BG., Vreeland MG, Larson LR, et al. Annual cost of care for Crohn's disease: a payor perspective. Am J Gastroenterol 2000 95 : 1955 60.
6. Feagan BG, Bala M, Yan S, et al. Unemployment and disability in patients with moderately to severely active Crohn's disease. J Clin Gastroenterol 2005 39 : 390 5.
7. Kasprzyk D, Montano DE, St Lawrence JS, et al. The effects of variations in mode of delivery and monetary incentive on physicians' responses to a mailed survey assessing STD practice patterns. Eval Health Prof 2001 24 : 3 17.
8. Asch DA, Christakis NA, Ubel PA. Conducting physician mail surveys on a limited budget. A randomized trial comparing $2 bill vs. $5 bill incentives. Med Care 1998 36 : 95 9.
9. Fitch K, Bernstein SJ, Aguilar M, et al. (eds) The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, The RAND Corporation, 2001
10. Brook RH., McGlynn EA, Shekelle PG. Defining and measuring quality of care: a perspective from US researchers. Int J Qual Health Care 2000 12 : 281 95.
11. Wennberg JE. Practice variations and health care reform: connecting the dots. Health Aff (Millwood). 2004 (Suppl Web Exclusive : VAR140 VAR144).
12. Colliver JA, Swartz MH. Assessing clinical performance with standardized patients. JAMA 1997 278 : 790 1.
13. Luck J, Peabody JW, Dresselhaus TR, et al. How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med 2000 108 : 642 9.
14. Glassman PA, Kravitz RL, Petersen LP, et al. Differences in clinical decision making between internists and cardiologists. Arch Intern Med 1997 157 : 506 12.
15. Carroll RG. Evaluation of vignette-type examination items for testing medical physiology. Am J Physiol 1993 264 : S11 5.
16. Jones TV, Gerrity MS, Earp J. Written case simulations: do they predict physicians' behavior J Clin Epidemiol 1990 43 : 805 15.
17. Peabody JW, Luck J, Glassman P, et al. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA 2000 283 : 1715 22.
18. Sriram TG, Chandrashekar CR, Isaac MK, et al. Training primary care medical officers in mental health care: an evaluation using a multiple-choice questionnaire. Acta Psychiatr Scand 1990 81 : 414 7.
19. Ryynanen OP, Myllykangas M, Kinnunen J, et al. Doctors' willingness to refer elderly patients for elective surgery. Fam Pract 1997 14 : 216 9.
20. Carey TS, Garrett J. Patterns of ordering diagnostic tests for patients with acute low back pain. The North Carolina Back Pain Project. Ann Intern Med 1996 125 : 807 14.
21. Spiegel BMR, Farid M, Esrailian E, et al. Is irritable bowel syndrome a diagnosis of exclusion? A vignette-based survey of IBS experts versus non-experts. Gastroenterology 2006 130 : A770.
22. Spiegel BMR, Farid M, Esrailian E, et al. Appropriateness of diagnostic testing in IBS: provider beliefs do not match published guidelines. Gastroenterology 2006 130 : A1134.
23. Esrailian E, Targownik LE, Spiegel BMR, et al. Is Wireless Capsule Endoscopy (WCE) appropriate for the diagnosis and management of Crohn's disease (CD)? A Survey of North American Inflammatory Bowel Disease (IBD) Experts. Gastroenterology 2005 128 A 73. Abstract 484
24. Hanauer SB., Stromberg U. Oral Pentasa in the treatment of active Crohn's disease: a meta-analysis of double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol 2004 2 : 379 88.
25. Akobeng AK, Gardener E. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease. Cochrane Database Syst Rev 2005 1 : CD003715
26. Camma C., Giunta M, Rosselli M, et al. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997 113 : 1465 73.
27. Steinhart AH, Hemphill D, Greenberg GR. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. Am J Gastroenterol 1994 89 : 2116 24.
28. Kamm MA. Debate: should mesalamine be used in Crohn's disease? Comments and conclusions. Inflamm Bowel Dis 2005 11 : 616 7.
29. Hanauer SB. The case for using 5-aminosalicyclates in Crohn's disease: pro. Inflamm Bowel Dis 2005 11 : 609 12.
30. Lim WC, Hanauer SB. Controversies with aminosalicylates in inflammatory bowel disease. Rev Gastroenterol Disord 2004 4 : 104 17.
31. Hanauer SB, Sandborn W Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol 2001 96 : 635 43.
32. Carter MJ, Lobo AJ, Travis SP IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004 53 (Suppl. 5 V1 16.
33. Reddy SI, Friedman S, Telford JJ, et al. Are patients with inflammatory bowel disease receiving optimal care Am J Gastroenterol 2005 100 : 1357 61.